Merck & Co Inc

MRK: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|r<LOCK|F&LOCK|$%%Tr>

Merck: Verona Acquisition a Logical Move That Fits Strategy

Merck announced plans to acquire Verona Pharma and its chronic obstructive pulmonary disease drug Ohtuvayre for $10 billion.

Sponsor Center